Ameriprise’s Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares CLVT.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-534,550
Closed -$20.3M 3991
2023
Q4
$20.3M Sell
534,550
-25,000
-4% -$785K 0.01% 1268
2023
Q3
$16.4M Hold
559,550
0.01% 1355
2023
Q2
$23M Sell
559,550
-335,000
-37% -$12.6M 0.01% 1170
2023
Q1
$36.9M Buy
894,550
+3,800
+0.4% +$171K 0.01% 903
2022
Q4
$33.7M Buy
890,750
+204,500
+30% +$8.59M 0.01% 911
2022
Q3
$29.3M Sell
686,250
-32,500
-5% -$1.73M 0.01% 948
2022
Q2
$41.1M Buy
718,750
+33,750
+5% +$2.07M 0.01% 804
2022
Q1
$46.5M Buy
685,000
+175,500
+34% +$11.9M 0.01% 840
2021
Q4
$46.2M Buy
+509,500
New +$45.8M 0.01% 884

Other funds holding CLVT.PRA

Ameriprise's CLVT.PRA Position: Q1 2024 in Review

Ameriprise sold out of Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares (CLVT.PRA) in Q1 2024, closing a stake of 534,550 shares — an estimated $20.3M sold.

Ameriprise first reported a position in CLVT.PRA in Q4 2021 and held it in 9 quarters. The position peaked at $46.5M in Q1 2022. 31 funds tracked by Wall St. Rank hold CLVT.PRA as of Q1 2024.

  • Ameriprise reported no remaining Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position as of Q1 2024 after selling out during the quarter.
  • Ameriprise sold 534,550 Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares shares in Q1 2024, an estimated $20.3M.
  • Ameriprise first reported a position in Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q4 2021 and held it in 9 quarters.
  • Ameriprise's Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position peaked at $46.5M in Q1 2022.
  • 31 funds tracked by Wall St. Rank held Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares as of Q1 2024.

Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.